TABLE 2

Drug-resistance profile of the 2217 Mycobacterium tuberculosis isolates included in the database stratified by lineage

LineageRHMDR-TBZSLIDsFQsXDR-TB
1 (EAI)32 (1.5)31 (1.6)30 (1.5)13 (1.0)0 (0.0)1 (0.20 (0.0)
2 (Beijing/East-Asian non-Beijing)638 (29.7)632 (31.9)630 (32.1)443 (34.4)337 (48.4)257 (44.2)179 (54.1)
3 (Delhi-CAS)63 (2.9)53 (2.7)53 (2.7)22 (1.7)2 (0.3)10 (1.7)1 (0.3)
4.1 (Euro-American)390 (18.1)347 (17.5)341 (17.4)206 (16.0)71 (10.2)77 (13.3)38 (11.5)
4.2 (Euro-American)199 (9.3)191 (9.6)189 (9.6)122 (9.5)48 (6.9)49 (8.4)25 (7.6)
4.3 (LAM)183 (8.5)166 (8.4)163 (8.3)95 (7.4)38 (5.5)50 (8.6)19 (5.7)
4.4, 4.5, 4.6 (Euro-American)77 (3.6)70 (3.5)69 (3.5)48 (3.7)22 (3.2)5 (0.9)1 (0.3)
4.7, 4.8, 4.9 (Euro-American)555 (25.8)483 (24.3)476 (24.3)333 (25.9)175 (25.1)131 (22.5)67 (20.2)
5 (West-Africa 1)1 (0.0)1 (0.1)1 (0.1)0 (0.0)0 (0.0)0 (0.0)0 (0.0)
Unknown13 (0.6)10 (0.5)10 (0.5)4 (0.3)4 (0.6)1 (0.2)1 (0.3)
Total2151 (97.0)1984 (89.5)1962 (88.5)1286 (58.0)697 (31.4)581 (26.8)331 (15.4)

Data are presented as n (%). R: rifampicin; H: isoniazid; MDR: multidrug resistant; TB: tuberculosis; Z: pyrazinamide; SLID: second-line injectable drug; FQ: fluoroquinolone; XDR: extensively drug resistant.